Flu vaccine manufacturing review
Executive Summary
FDA's Vaccines & Related Biological Products Advisory Committee will review the use of Madin-Darby canine kidney cells for the manufacture of inactivated influenza vaccines Nov. 16. The committee will discuss the development of new pneumococcal vaccines for adults on Nov. 17. The meeting will be held at the Holiday Inn Select in Bethesda, Md., beginning at 8:30 a.m. both days. [Editor's Note: To 1watch a webcastor order a video/DVD of this meeting, visit FDAAdvisoryCommittee.com]...